High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial
- 1 November 2000
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 356 (9241) , 1554-1559
- https://doi.org/10.1016/s0140-6736(00)03126-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Late clonal diseases of treated aplastic anemiaSeminars in Hematology, 2000
- Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy-the European group for blood and marrow transplantation experienceSeminars in Hematology, 2000
- Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experienceKlinische Padiatrie, 1998
- The Pathophysiology of Acquired Aplastic AnemiaNew England Journal of Medicine, 1997
- Current Therapies for Systemic VasculitisSeminars in Neurology, 1994
- Editorial Response: Evolving Risk Factors for Invasive Fungal Infections--All Neutropenic Patients Are Not the SameClinical Infectious Diseases, 1994
- Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working PartyBritish Journal of Haematology, 1993
- Treatment of Aplastic Anemia with Antilymphocyte Globulin and Methylprednisolone with or without CyclosporineNew England Journal of Medicine, 1991
- Infection and CyclosporineClinical Infectious Diseases, 1989
- The effect of cyclophosphamide on T lymphocytes and T lymphocyte subsets in patients with chronic progressive multiple sclerosisActa Neurologica Scandinavica, 1984